Literature DB >> 25690625

Biomechanical performance of baseball pitchers with a history of ulnar collateral ligament reconstruction.

Glenn S Fleisig1, Charles E Leddon2, Walter A Laughlin3, Michael G Ciccotti4, Bert R Mandelbaum5, Kyle T Aune3, Rafael F Escamilla6, Toran D MacLeod7, James R Andrews8.   

Abstract

BACKGROUND: A relatively high number of active professional baseball pitchers have a history of ulnar collateral ligament reconstruction (UCLr) on their throwing elbow. Controversy exists in the literature about whether professional baseball pitchers regain optimal performance after return from UCLr. It has been suggested that pitchers may have different biomechanics after UCLr, but this has not been previously tested. HYPOTHESIS: It was hypothesized that, compared with a control group without a history of UCLr, professional pitchers with a history of UCLr would have (1) significantly different throwing elbow and shoulder biomechanics; (2) a shortened stride, insufficient trunk forward tilt, and excessive shoulder horizontal adduction, characteristics associated with "holding back" or being tentative; (3) late shoulder rotation; and (4) improper shoulder abduction and trunk lateral tilt. STUDY
DESIGN: Controlled laboratory study.
METHODS: A total of 80 active minor league baseball pitchers (and their 8 Major League Baseball organizations) agreed to participate in this study. Participants included 40 pitchers with a history of UCLr and a matched control group of 40 pitchers with no history of elbow or shoulder surgery. Passive ranges of motion were measured for each pitcher's elbows and shoulders, and then 23 reflective markers were attached to his body. The pitcher took as many warm-up pitches as desired and then threw 10 full-effort fastballs for data collection. Ball speed was recorded with a radar gun. The reflective markers were tracked with a 10-camera, 240-Hz automated motion analysis system. Eleven biomechanical parameters were computed for each pitch and then averaged for each participant. Demographic, range of motion, and biomechanical parameters were compared between the UCLr group and the control group by use of Student t tests (significance set at P<.05).
RESULTS: All hypotheses were rejected, as there were no differences in pitching biomechanics between the UCLr group and the control group. There were also no differences in passive range of motion between the 2 groups.
CONCLUSION: Compared with a control group, active professional pitchers with a history of UCLr displayed no significant differences in shoulder and elbow passive range of motion and no significant differences in elbow and shoulder biomechanics. CLINICAL RELEVANCE: Clinical studies have previously shown that 10% to 33% of professional pitchers do not return to their preinjury level; however, the current study showed that those pitchers who successfully return to professional baseball after UCLr pitch with biomechanics similar to that of noninjured professionals.
© 2015 The Author(s).

Entities:  

Keywords:  Tommy John surgery; elbow varus torque; kinematics; kinetics

Mesh:

Year:  2015        PMID: 25690625     DOI: 10.1177/0363546515570464

Source DB:  PubMed          Journal:  Am J Sports Med        ISSN: 0363-5465            Impact factor:   6.202


  14 in total

1.  Fastball Velocity and Elbow-Varus Torque in Professional Baseball Pitchers.

Authors:  Jonathan S Slowik; Kyle T Aune; Alek Z Diffendaffer; E Lyle Cain; Jeffrey R Dugas; Glenn S Fleisig
Journal:  J Athl Train       Date:  2019-02-05       Impact factor: 2.860

2.  Kinematic and kinetic analyses of professional pitchers with history of core or groin injuries: A propensity-score matched analysis.

Authors:  Joseph E Manzi; Elizabeth Dennis; Grant G Black; Nicolas Trauger; Theodore Quan; Kathryn D McElheny; Joshua S Dines
Journal:  J Orthop       Date:  2022-03-01

3.  Do Major League Baseball Team Physicians Harvest the Semitendinosus From the Drive Leg or Landing Leg When Performing Ulnar Collateral Ligament Reconstruction on Elite Baseball Pitchers?

Authors:  Brandon J Erickson; Peter N Chalmers; Jeffrey R Dugas; Bernard R Bach; Gregory P Nicholson; Nikhil N Verma; Christopher S Ahmad; Anthony A Romeo
Journal:  Orthop J Sports Med       Date:  2017-07-03

4.  Biomechanical Analysis of Weighted-Ball Exercises for Baseball Pitchers.

Authors:  Glenn S Fleisig; Alek Z Diffendaffer; Kyle T Aune; Brett Ivey; Walter A Laughlin
Journal:  Sports Health       Date:  2016-11-01       Impact factor: 3.843

5.  Effects of Ulnar Collateral Ligament Reconstruction on Pitch Selection in Major League Baseball Pitchers.

Authors:  Eric E Peterson; Patrick Handwork; Lonnie Soloff; Mark S Schickendantz; Salvatore J Frangiamore
Journal:  Orthop J Sports Med       Date:  2018-11-20

6.  Influence of Pitching Release Location on Ulnar Collateral Ligament Reconstruction Risk Among Major League Baseball Pitchers.

Authors:  Daniel A Portney; Lucas T Buchler; Jake M Lazaroff; Stephen M Gryzlo; Matthew D Saltzman
Journal:  Orthop J Sports Med       Date:  2019-02-21

7.  Biomechanical Differences Between Japanese and American Professional Baseball Pitchers.

Authors:  Takanori Oi; Shinichi Yoshiya; Jon Slowik; Alek Diffendaffer; Yohei Takagi; Hiroshi Tanaka; Katsuya Nobuhara; Glenn S Fleisig
Journal:  Orthop J Sports Med       Date:  2019-02-19

8.  Baseball Pitching Biomechanics Shortly After Ulnar Collateral Ligament Repair.

Authors:  Glenn S Fleisig; Alek Z Diffendaffer; Monika Drogosz; E Lyle Cain; Benton A Emblom; Jeffrey R Dugas
Journal:  Orthop J Sports Med       Date:  2019-08-27

Review 9.  Optimal management of ulnar collateral ligament injury in baseball pitchers.

Authors:  Elizabeth E Hibberd; J Rodney Brown; Joseph T Hoffer
Journal:  Open Access J Sports Med       Date:  2015-11-11

10.  Effects of a six-week weighted-implement throwing program on baseball pitching velocity, kinematics, arm stress, and arm range of motion.

Authors:  Joseph A Marsh; Matthew I Wagshol; Kyle J Boddy; Michael E O'Connell; Sam J Briend; Kyle E Lindley; Alex Caravan
Journal:  PeerJ       Date:  2018-11-23       Impact factor: 2.984

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.